iBio-logo.jpg
iBio to Participate in the 33rd Annual Roth Conference
March 09, 2021 16:30 ET | iBio, Inc.
BRYAN, Texas, March 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that it...
iBio-logo.jpg
iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update
February 16, 2021 16:05 ET | iBio, Inc.
BRYAN, Tx., Feb. 16, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial...
iBio-logo.jpg
iBio Appoints Robert M. Lutz as Chief Financial & Business Officer
February 16, 2021 08:00 ET | iBio, Inc.
BRYAN, Texas, Feb. 16, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the...
ibio new copy
iBio to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Update on Tuesday, February 16, 2021
February 09, 2021 16:30 ET | iBio, Inc.
BRYAN, Texas, Feb. 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will...
ibio (1).jpg
iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer
December 28, 2020 07:30 ET | iBio, Inc.
BRYAN, Texas, Dec. 28, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the...
ibio (1).jpg
iBio Announces Closing of its Public Offering of Common Stock
December 10, 2020 16:30 ET | iBio, Inc.
BRYAN, Texas, Dec. 10, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the closing...
ibio (1).jpg
iBio Announces Pricing of $35 Million Public Offering of Common Stock
December 08, 2020 08:55 ET | iBio, Inc.
BRYAN, Texas, Dec. 08, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the pricing...
ibio (1).jpg
iBio Announces Proposed Public Offering of Common Stock
December 07, 2020 16:01 ET | iBio, Inc.
BRYAN, Texas, Dec. 07, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced an...
ibio (1).jpg
iBio Selected to Produce ATB Therapeutics’ Bioengineered Antibody-Toxin Fusion Proteins
December 01, 2020 16:30 ET | iBio, Inc.
BRYAN, Texas, Dec. 01, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract development and manufacturing organization (“CDMO”),...
ibio (1).jpg
iBio Announces Issuance of U.S. Patent Covering Endostatin Peptides for Treating Fibrosis
November 24, 2020 07:30 ET | iBio, Inc.
BRYAN, Texas, Nov. 24, 2020 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that the...